Cochlear Limited (original) (raw)

dbo:abstract

Cochlear ist ein weltweit tätiges Medizintechnik-Unternehmen, das implantierbare Hörhilfen entwickelt, produziert und vertreibt. Es wurde 1981 gegründet und hat seinen Hauptsitz in Sydney (Australien). Seit 1995 ist Cochlear eine börsennotierte Aktiengesellschaft. Die deutsche Niederlassung von Cochlear hat ihren Sitz in Hannover (Niedersachsen). (de)
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Based in Sydney, Cochlear was formed in 1983 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015. Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. (en)
Cochlear – australijski producent implantów ślimakowych Nucleus i kostnych Baha. W 2007 roku firma zatrudniała 1655 osób. (pl)

dbo:foundingYear

1983-01-01 (xsd:gYear)

dbo:industry

dbr:Biotechnology

dbo:location

dbo:numberOfEmployees

4000 (xsd:nonNegativeInteger)

dbo:product

dbo:thumbnail

wiki-commons:Special:FilePath/Cochlear_Limited_Logo_new_branding_from_2020.png?width=300

dbo:type

dbr:Public_company

dbo:wikiPageExternalLink

dbo:wikiPageID

7614196 (xsd:integer)

dbo:wikiPageLength

38274 (xsd:nonNegativeInteger)

dbo:wikiPageRevisionID

1123610344 (xsd:integer)

dbo:wikiPageWikiLink

dbp:foundation

1983 (xsd:integer)

dbp:homepage

http://www.cochlear.com/

dbp:industry

dbr:Biotechnology

dbp:keyPeople

Dig Howitt (en)
Rick Holliday-Smith (en)

dbp:location

dbp:logo

Cochlear_Limited_Logo_new_branding_from_2020.png (en)

dbp:name

Cochlear Limited (en)

dbp:numEmployees

4000 (xsd:integer)

dbp:products

Bone anchored prosthetics (en)
Bone-anchored hearing aids (en)
Cochlear implants (en)
Cochlear wireless accessories (en)

dbp:profit

A$224 million ( ) (en)

dbp:revenue

1240000000 (xsd:integer)

dbp:type

dbr:Public_company

dbp:wikiPageUsesTemplate

dbp:wordnet_type

http://www.w3.org/2006/03/wn/wn20/instances/synset-company-noun-1

dcterms:subject

gold:hypernym

dbr:Company

schema:sameAs

http://viaf.org/viaf/302663553

rdf:type

rdfs:comment

Cochlear ist ein weltweit tätiges Medizintechnik-Unternehmen, das implantierbare Hörhilfen entwickelt, produziert und vertreibt. Es wurde 1981 gegründet und hat seinen Hauptsitz in Sydney (Australien). Seit 1995 ist Cochlear eine börsennotierte Aktiengesellschaft. Die deutsche Niederlassung von Cochlear hat ihren Sitz in Hannover (Niedersachsen). (de)
Cochlear – australijski producent implantów ślimakowych Nucleus i kostnych Baha. W 2007 roku firma zatrudniała 1655 osób. (pl)
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Based in Sydney, Cochlear was formed in 1983 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015. (en)

rdfs:label